Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 9/20 | 0.35 |
| ▸ | KCNJ11 | Q14654 | 9/20 | 0.35 |
| ▸ | ABCC8 | Q09428 | 8/20 | 0.35 |
| ▸ | KCNJ8 | Q15842 | 8/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL878061 | 0.87 | ABCC9 (0.31) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL15132596 | 0.75 | BACE1 (0.40) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL7457537 | 0.74 | ABCC9 (0.31) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL878338 | 0.73 | ABCC9 (0.31) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL14855984 | 0.73 | ABCC9 (0.33) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL877591 | 0.72 | KMT2A (0.40) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL15124792 | 0.72 | KMT2A (0.40) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL10082098 | 0.68 | BACE1 (0.37) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL15124391 | 0.68 | BACE1 (0.37) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL878090 | 0.68 | BACE1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2619207-B1 | 4,7-Dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta secretase (BACE) | JANSSEN PHARMACEUTICA NV (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8609660-B2 | 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE) | JANSSEN PHARMACEUTICA NV (BE) | 2013-12-17 | — | — | US | disclosed |
| EP-2619207-A1 | 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | Janssen Pharmaceutica, N.V. (BE) | 2013-07-31 | — | — | EP | disclosed |
| US-20130190318-A1 | 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | JANSSEN PHARMACEUTICA NV (US) | 2013-07-25 | — | — | US | disclosed |
| WO-2012038438-A1 | 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | JANSSEN PHARMACEUTICA NV (BE) | 2012-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190318-A1 | 4,7-DIHYDRO-PYRAZOLO[1,5-a]PYRAZIN-6-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | BACE2, BACE1, PSEN2 | ABCC9 3811/4885KCNJ11 4216/4885ABCC8 3826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.